Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 19Terminated 6Withdrawn 1Unknown 1No longer available 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 15Leukemia, Lymphocytic, Chronic, B-Cell 11Burkitt Lymphoma 10Lymphoma 9Leukemia 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Follicular 8Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 7Myelodysplastic Syndromes 6Multiple Myeloma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Myeloproliferative Disorders 5Lymphoma, Large B-Cell, Diffuse 5Hodgkin Disease 5Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Hematologic Neoplasms 4Congenital Abnormalities 4Sezary Syndrome 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Leukemia, Biphenotypic, Acute 3Waldenstrom Macroglobulinemia 2Recurrence 2Primary Myelofibrosis 2Neoplasms, Plasma Cell 2

Interventions

Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Doxorubicin 2Cytarabine 2Cyclophosphamide 2sargramostim 1romidepsin 1fludarabine phosphate 1ethanolamine oleate 1duvelisib 1denileukin diftitox 1cc-486 1Whole-Body Irradiation 1Vincristine 1Valganciclovir 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Transplantation 1Thiotepa 1Tacrolimus 1Sulfamethoxazole 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Radiotherapy 1Psychiatric Rehabilitation 1Prednisone 1Polymerase Chain Reaction 1Pentetic Acid 1Ondansetron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Lymphoma, Extranodal NK-T-Cell × fludarabine phosphate × Clear all
NCT01652014 2016-07-14

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Rutgers, The State University of New Jersey

Phase 2 Withdrawn
DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myeloproliferative Disorders, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡